Penlac and Sweating - excessive - a phase IV clinical study of FDA data

Summary:

Sweating - excessive is reported as a side effect among people who take Penlac (ciclopirox), especially for people who are female, 50-59 old, also take Levaquin, and have Pain.

The phase IV clinical study analyzes which people have Sweating - excessive when taking Penlac. It is created by eHealthMe based on reports of 488 people who have side effects when taking Penlac from the FDA, and is updated regularly.

What is Penlac?

Penlac has active ingredients of ciclopirox. eHealthMe is studying from 492 Penlac users. Check the latest studies of Penlac.

What is Sweating - excessive?

Sweating - excessive is found to be associated with 3,355 drugs and 3,628 conditions by eHealthMe. Check the latest studies of Sweating - excessive.

On Jul, 22, 2026

488 people reported to have side effects when taking Penlac.
Among them, 15 people (3.07%) have Sweating - excessive.

Could Penlac cause Sweating - excessive?

Among these 15 people:

What is the gender of people who have Sweating - excessive when taking Penlac? *

female: 73.33 %
male: 26.67 %

What is the age of people who have Sweating - excessive when taking Penlac? *

What are other drugs people take besides Penlac? *

Claritin: 7 people, 46.67%
Levaquin: 7 people, 46.67%
Ambien: 6 people, 40.00%
Ativan: 6 people, 40.00%
Esomeprazole Magnesium: 6 people, 40.00%
Colace: 5 people, 33.33%
Lyrica: 5 people, 33.33%
Dexamethasone: 5 people, 33.33%
Neurontin: 5 people, 33.33%
Ms Contin: 5 people, 33.33%

What are other side effects people have besides Sweating - excessive? *

Fatigue (feeling of tiredness): 10 people, 66.67%
Stress And Anxiety: 10 people, 66.67%
Weakness: 9 people, 60.00%
Back Pain: 9 people, 60.00%
Nausea (feeling of having an urge to vomit): 8 people, 53.33%
Rashes (redness): 8 people, 53.33%
Dyspnea (difficult or laboured breathing): 8 people, 53.33%
Joint Pain: 8 people, 53.33%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 8 people, 53.33%
Dizziness: 7 people, 46.67%

What are the existing conditions these people have? *

Pain: 7 people, 46.67%
Nausea (feeling of having an urge to vomit): 5 people, 33.33%
Constipation: 5 people, 33.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 20.00%
High Blood Pressure: 3 people, 20.00%
Sinus Congestion (blockage of sinus): 2 people, 13.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 13.33%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 13.33%
Neuralgia (pain in one or more nerves): 2 people, 13.33%
Nail Disorder (disease of nail): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Penlac and have Sweating - excessive?

- Check whether Sweating - excessive is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Penlac:

Penlac (492 reports)

Browse all side effects of Penlac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sweating - excessive:

Sweating - excessive (3,355 drugs)

Browse all the conditions that are associated with Sweating - excessive:

Sweating - excessive (3,628 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ciclopirox (the active ingredients of Penlac) and Penlac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.